TRODELVY 180 mg

TRODELVY 180 mg is a medicine authorised by Swissmedic under authorisation number 68179. The authorisation holder is Gilead Sciences Switzerland Sàrl. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 09 September 2021 and the authorisation is valid without a time limit. ATC code L01FX17 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 68179
  • ATC L01FX17
  • Biotechnological medicines
Authorisation data
Authorisation number68179
NameTRODELVY 180 mg
Full nameTRODELVY 180 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderGilead Sciences Switzerland Sàrl
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01FX17
First authorisation09 September 2021
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1TRODELVY 180 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungA09 September 2021

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01FX1707.16.1.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is TRODELVY 180 mg authorised in Switzerland?

Yes. TRODELVY 180 mg is authorised by Swissmedic under authorisation number 68179, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does TRODELVY 180 mg have?

TRODELVY 180 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of TRODELVY 180 mg?

The authorisation holder is Gilead Sciences Switzerland Sàrl. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com